Get the tools used by (smart)2 investors.
SP500 0.1%DOW -1.4%FTSE 100 0.1%NIKKEI 1.3%OIL 2.5%GOLD -0.4%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Laurus Labs LtdBSE:540222

India / Healthcare / Pharmaceuticals

Laurus Labs Limited (540222)
Dr. Reddy's Laboratories Limited (DRREDDY)
Alivus Life Sciences Limited (ALIVUS)
Hikal Limited (HIKAL)
Ajanta Pharma Limited (AJANTPHARM)
Aurobindo Pharma Limited (AUROPHARMA)
NATCO Pharma Limited (NATCOPHARM)

Performance vs Valuation Benchmarks

-6.0%0.5%7.0%13.5%20.0%0.0x50.0x100.0x150.0x200.0x250.0x300.0x540222DRREDDYALIVUSHIKALAJANTPHARMAUROPHARMANATCOPHARM
XAxis
Revenue Growth
YAxis
P/E Ratio
Size
Market Cap

Price Performance History

Price History Unavailable

Summary Table

Name
Price, Current
Fair Value (FINBOX)
Fair Value Label (FINBOX)
Fair Value (Analyst Targets)
Fair Value Label (Analyst Targets)
Label
Market Cap
Dividend Per Share
Dividend Yield
Relative Strength Index (14d)
P/E Ratio
Price / Book
Price / LTM Sales
Enterprise Value (EV)
Total Debt / Total Capital
Float Shares / Outstanding
540222
Laurus Labs Limited
₹627.350.1%
₹440.80
-29.7% Downside
Overvalued
₹500
-20.3% Downside
Fair
fair
338.7 B
₹0.8000
0.1%
60.26
169.1x
8.2x
6.4x
366.2 B
7.6%
67.8%
AJANTPHARM
Ajanta Pharma Limited
₹2,6922.1%
₹2,355
-12.5% Downside
Fair
₹3,105
15.4% Upside
Fair
great
336.5 B
₹54
2.0%
57.69
37.5x
9.2x
7.4x
329.4 B
0.1%
33.5%
ALIVUS
Alivus Life Sciences Limited
₹989.101.1%
₹867.94
-12.2% Downside
Fair
₹1,338
35.2% Upside
Undervalued
good
121.2 B
₹0
0.0%
48.72
27.4x
4.8x
5.3x
116.9 B
0.1%
25.0%
AUROPHARMA
Aurobindo Pharma Limited
₹1,1713.3%
₹1,333
13.9% Upside
Fair
₹1,495
27.7% Upside
Undervalued
good
680.5 B
₹4.5000
0.4%
58.28
19.5x
2.2x
2.2x
696.1 B
11.0%
47.0%
DRREDDY
Dr. Reddy's Laboratories Limited
₹1,1630.4%
₹1,396
20.0% Upside
Fair
₹1,326
14.0% Upside
Fair
great
969.5 B
₹8
0.7%
56.38
18.1x
3.1x
3.1x
964.5 B
5.0%
71.5%
HIKAL
Hikal Limited
₹4330.0%
₹340.48
-21.4% Downside
Fair
₹450
3.9% Upside
Fair
fair
53.198 B
₹1.2000
0.3%
63.48
71.3x
4.4x
2.9x
60.587 B
12.7%
30.9%
NATCOPHARM
NATCO Pharma Limited
₹828.150.2%
₹1,141
37.7% Upside
Undervalued
₹1,095
32.2% Upside
Undervalued
excellent
148.2 B
₹6
0.7%
54.79
7.9x
2.1x
3.5x
125.8 B
1.4%
62.5%
10
30
50
100
All rights reserved. Terms Of Use
Could not load asset details. Please reload the page or contact support.